Adaptimmune Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2016

Computer equipment		3 years
Laboratory equipment		5 years
Office equipment		5 years
Leasehold improvements		the expected duration of the lease

The following table reconciles the numerator and denominator in the basic and diluted earnings/loss per share computation (in thousands):

	for the three months ended March 31,
	2016			2015
Numerator for basic and diluted EPS
Net loss	$	(15,576	)	$	(1,945	)
Deemed dividend on convertible preferred shares	—			(6,434		)

Net loss available to ordinary shareholders	$	(15,576	)	$	(8,379	)


Denominator for basic and diluted EPS
Weighted average number of shares used to calculate basic and diluted loss per share	424,711,900			181,370,100

	for the three months ended March 31,
	2016	2015
	Number	Number
Share options	44,159,031	29,951,662
Preferred shares	—	175,841,800